|
|
Pharmaceuticals: Europe Industry Guide |
| Published Date : 17 February 2010 |
|
Pages : 65 |
|
|
|
|
|
|
|
|
|
Pharmaceuticals: Europe Industry Guide is an essential resource for top-level data and analysis covering the Europe Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The European pharmaceuticals market generated total revenues of $187,306.7 million in 2009, representing a compound annual growth rate (CAGR) of 4.1% for the period spanning 2005-2009.
* The European OTC pharmaceuticals market generated total revenues of $38.9 billion in 2008, representing a compound annual growth rate (CAGR) of 3.1% for the period spanning 2004-2008.
* The European biotechnology market generated total revenues of $46.1 billion in 2008, representing a compound annual growth rate (CAGR) of 8.5% for the period spanning 2004-2008.
* The European generics market generated total revenues of $38.5 billion in 2008, representing a compound annual growth rate (CAGR) of 12.9% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research |
|
|
|
Table of Contents : |
" CHAPTER 1 BIOTECHNOLOGY IN EUROPE 9 1.1 Market Overview 9 1.2 Market Value 11 1.3 Market Segmentation I 12 1.4 Market Segmentation II 13 1.5 Five Forces Analysis 14 1.6 Market Forecasts 20 CHAPTER 2 GENERICS IN EUROPE 21 2.1 Market Overview 21 2.2 Market Value 23 2.3 Market Segmentation I 24 2.4 Market Segmentation II 25 2.5 Five Forces Analysis 26 2.6 Market Forecasts 33 CHAPTER 3 OTC PHARMACEUTICALS IN EUROPE 34 3.1 Market Overview 34 3.2 Market Value 36 3.3 Market Segmentation I 37 3.4 Market Segmentation II 38 3.5 Market Share 39 3.6 Five Forces Analysis 40 3.7 Distribution 48 3.8 Market Forecasts 49 CHAPTER 4 PHARMACEUTICALS IN EUROPE 50 4.1 Market Overview 50 4.2 Market Value 52 4.3 Market Segmentation I 53 4.4 Market Segmentation II 54 4.5 Market Share 55 4.6 Five Forces Analysis 56 4.7 Market Forecasts 63 CHAPTER 5 MACROECONOMIC INDICATORS 64 CHAPTER 6 APPENDIX 65 6.1 Data Research Methodology 65
LIST OF TABLES Table 1: Europe Biotechnology Market Value: $ billion, 2004-2008 11 Table 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2008 12 Table 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2008 13 Table 4: Europe Biotechnology Market Value Forecast: $ billion, 2008-2013 20 Table 5: Europe Generics Market Value: $ billion, 2004-2008 23 Table 6: Europe Generics Market Segmentation I: % Share, by Value, 2008 24 Table 7: Europe Generics Market Segmentation II: % Share, by Value, 2008 25 Table 8: Europe Generics Market Value Forecast: $ billion, 2008-2013 33 Table 9: Europe OTC Pharmaceuticals Market Value: $ billion, 2004-2008 36 Table 10: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 37 Table 11: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 38 Table 12: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2008 39 Table 13: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008 48 Table 14: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49 Table 15: Europe Pharmaceuticals Market Value: $ billion, 2005-2009 52 Table 16: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 53 Table 17: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 54 Table 18: Europe Pharmaceuticals Market Share: % Share, by Volume, 2009 55 Table 19: Europe Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 63 Table 20: Europe Exchange Rate, 2004-2008 64
LIST OF FIGURES Figure 1: Europe Biotechnology Market Value: $ billion, 2004-2008 11 Figure 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2008 12 Figure 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2008 13 Figure 4: Forces Driving Competition in the Biotechnology Market in Europe, 2008 14 Figure 5: Drivers of Buyer Power in the Biotechnology Market in Europe, 2008 15 Figure 6: Drivers of Supplier Power in the Biotechnology Market in Europe, 2008 16 Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Europe, 2008 17 Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Europe, 2008 18 Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Europe, 2008 19 Figure 10: Europe Biotechnology Market Value Forecast: $ billion, 2008-2013 20 Figure 11: Europe Generics Market Value: $ billion, 2004-2008 23 Figure 12: Europe Generics Market Segmentation I: % Share, by Value, 2008 24 Figure 13: Europe Generics Market Segmentation II: % Share, by Value, 2008 25 Figure 14: Forces Driving Competition in the Generics Market in Europe, 2008 26 Figure 15: Drivers of Buyer Power in the Generics Market in Europe, 2008 28 Figure 16: Drivers of Supplier Power in the Generics Market in Europe, 2008 29 Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2008 30 Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2008 31 Figure 19: Drivers of Degree of Rivalry in the Generics Market in Europe, 2008 32 Figure 20: Europe Generics Market Value Forecast: $ billion, 2008-2013 33 Figure 21: Europe OTC Pharmaceuticals Market Value: $ billion, 2004-2008 36 Figure 22: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 37 Figure 23: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 38 Figure 24: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2008 39 Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Europe, 2008 40 Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Europe, 2008 42 Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Europe, 2008 43 Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Europe, 2008 44 Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Europe, 2008 46 Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Europe, 2008 47 Figure 31: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2008 48 Figure 32: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49 Figure 33: Europe Pharmaceuticals Market Value: $ billion, 2005-2009 52 Figure 34: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 53 Figure 35: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 54 Figure 36: Europe Pharmaceuticals Market Share: % Share, by Volume, 2009 55 Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Europe, 2009 56 Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Europe, 2009 58 Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Europe, 2009 59 Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe, 2009 60 Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe, 2009 61 Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe, 2009 62 Figure 43: Europe Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 63 |
|
|
|
Published By : Datamonitor |
|
|
Related
Keywords:
Energy,
Insurance, Financial,
Company Profile,
Industry Profile,
Swot Analysis,
Apparel,
Consumer, Trade,
Information technology,
Food,
Healthcare,
Construction,
Retail,
Design,Oil
and Gas,
Solar,
Miscellaneous,
Business,
Pharmaceuticals,
Technology,
Defense,
Medical,
Travel,
Power,
Metal
|
|
|
|